Luong, Tiffany
Cukierman, Edna http://orcid.org/0000-0002-1452-9576
Funding for this research was provided by:
National Institutes of Health (R01CA232256, R01CA232256)
Eisai Incorporated (N/A, N/A)
Marvin & Concetta Greenberg Pancreatic Cancer Institute Funds (N/A, N/A)
Pancreatic Cancer Cure Foundation (N/A)
Pennsylvania’s DOH Research Formula Funds (N/A)
5th AHEPA Cancer Research Foundation, Inc. (N/A)
Worldwide Cancer Research (20-0081)
Article History
Received: 28 February 2022
Accepted: 17 November 2022
First Online: 2 December 2022
Declarations
:
: All fibroblastic human cells used in this study, were harvested from surgical patient samples in accordance with guidelines and regulations at Fox Chase Cancer Center following institutional biosafety policies. Fresh surgical samples were collected by the Biosample Repository Facility (BRF) at Fox Chase Cancer Center. Prior to surgery, patients interested in donating tissue for research are informed on how the tissue is collected, processed, and distributed, as well as the type of data and decoding process that is undertaken by the BRF personnel. If patients agree, they proceed to sign a written consent that was approved by the Institutional Review Board (IRB) protocol at Fox Chase. To assure protecting the patient identities and specifically for this study, solely the BRF-generated specimen number and organ of origin were conveyed to the research team. All cells used in this study were harvested from surgical samples that were obtained from patients who signed a consent allowing to decode their samples and use the anonymized materials for research according to the approved IRB protocol at Fox Chase. Hence, while no human subjects were used in this study the authors confirm that the experimental protocols were approved by the corresponding Fox Chase IBC, IRB and licensing committees.
: Not applicable.
: The authors declare that funding from Eisai Inc supported the research conveyed in this study. Further, EC declares having received consultation fees from Phenomic AI and Takeda.